CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.

Andere talen China Resources Double-Crane Pharmaceutical Co.,Ltd.

Aandelen

600062

CNE000000Q94

slotkoers Shanghai S.E. Andere beurzen 00:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
21,38 ^CNY	+0,99%		+3,99%	+14,95%

25/04	China Resources Double-Crane Pharmaceutical Co.,Ltd. Rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
26/03	CR Double-Crane Pharma Unit ontvangt goedkeuring voor medicijn tegen epilepsie	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
CR Double-Crane Pharmaceutical Gets Nod to Trial Semaglutide Injection	16/04
CR Double-Crane Pharma Unit Receives Approval for Epilepsy Drug	26/03
CR Double-Crane Pharma's 2023 Profit Jumps 13%, Operating Income Climbs 6%	22/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. Proposes Cash Dividend	21/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
CR Double-crane Pharmaceutical Gets Nod to Market Doxazosin Mesylate Tablets	12/03
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire China Resources Zizhu Pharmaceutical Co., Ltd. from Beijing Pharmaceutical Group Co., Ltd. for CNY3.1 billion.	26/02
CR Double-Crane Pharma Gets Nod for Apixaban Tablets; Unit's Clozapine Orally Disintegrating Tablets Gets Greenlight for Proposed Amendments	21/02
CR Double-Crane Pharma's Unit Gets Nod to Market Lithium Carbonate Drug Ingredient	08/02
CR Double-Crane Pharmaceutical's Unit Gets Nod to Raise Strength of Viagra Drug	31/01
China Includes CR Double-Crane Pharmaceutical's Two Drugs in List of Insurance-Backed Drugs	14/12
CR Double-Crane Pharma Unit Gets Nod to Amend Sodium Lactate Ringer Injection's Details	12/12
China Resources Double-Crane Pharmaceutical Co.,Ltd.(SHSE:600062) dropped from Shanghai Stock Exchange 180 Value Index	08/12
China Resources Double-Crane Pharmaceutical Co.,Ltd.(SHSE:600062) dropped from SSE 180 Index	08/12
China Resources Double-Crane Pharmaceutical Co.,Ltd. completed the acqyusution 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd.	03/11
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26-10-23
CR Double-Crane Pharma to Buy 90% Stake in Local Peer For 260 Million Yuan	28-09-23
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd for CNY 260 million	28-09-23
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen China Resources Double-Crane Pharmaceutical Co.,Ltd.

Aandelen

600062

CNE000000Q94

Andere talen

Filters